Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel Free UTHR Stock Alerts

United Therapeutics (UTHR) Short Interest Ratio & Short Volume

United Therapeutics logo
$529.05 -2.74 (-0.52%)
Closing price 04:00 PM Eastern
Extended Trading
$528.71 -0.34 (-0.06%)
As of 04:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

United Therapeutics Short Interest Overview

As of June 30, 2026, United Therapeutics (UTHR) had a short interest of 2.12 million shares sold short, representing 5.46% of the public float. This marks a 3.16% increase in short interest since the prior report. The short interest ratio (days to cover) is 2.9, meaning it would take 2.9 days of the average trading volume of 509,624 shares to cover all short positions.

Current Short Interest
2,117,787 shares
Previous Short Interest
2,052,888 shares
Change Vs. Previous Month
3.16%
Dollar Volume Sold Short
$1.15 billion
Short Interest Ratio
2.9 Days to Cover
Last Record Date
June 30, 2026
Outstanding Shares
42,450,000 shares
Short Percent of Float
5.46%
Today's Trading Volume
350,859 shares
Average Trading Volume
509,624 shares
Today's Volume Vs. Average
69%
Short Selling United Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for United Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

UTHR Short Interest Over Time

UTHR Days to Cover Over Time

UTHR Percentage of Float Shorted Over Time

United Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/20262,117,787 shares $1.15 billion +3.2%5.5%2.91 $541.83
6/15/20262,052,888 shares $1.13 billion -6.3%5.3%4.64 $549.57
5/29/20262,191,540 shares $1.22 billion -4.9%5.6%4.52 $556.82
5/15/20262,303,877 shares $1.31 billion -5.9%5.9%4.97 $568.58
4/30/20262,449,350 shares $1.40 billion -9.4%6.3%6.49 $571.35
4/15/20262,703,199 shares $1.56 billion -4.7%7.0%4.83 $577.58
2/13/20261,842,287 shares $872.62 million +6.6%4.7%6.09 $473.66
11/14/20251,650,438 shares $769.76 million -1.9%4.1%3.64 $466.40
10/31/20251,683,024 shares $749.67 million -17.3%4.2%2.61 $445.43
10/15/20252,030,000 shares $877.35 million -7.3%4.6%2.5 $432.19
9/30/20252,190,000 shares $918.07 million -21.2%5.0%2.8 $419.21
9/15/20252,780,000 shares $1.12 billion +3.0%6.4%3.9 $403.11
8/31/20252,700,000 shares $822.85 million -5.6%6.2%3.7 $304.76
8/15/20252,860,000 shares $895.55 million +82.2%6.5%4.5 $313.13
7/31/20251,570,000 shares $431.28 million -1.9%3.6%2.6 $274.70
7/15/20251,600,000 shares $469.18 million +2,016.4%3.6%3 $293.24
6/30/202575,600 shares $21.72 million -95.3%0.2%0.3 $287.35
6/15/20251,610,000 shares $456.19 million -14.4%3.7%2.9 $283.35
5/31/20251,880,000 shares $594.72 million -10.5%4.3%3.7 $316.34
5/15/20252,100,000 shares $638.23 million +6.6%4.8%4.1 $303.92
4/30/20251,970,000 shares $597.09 million +18.7%4.5%3.9 $303.09
4/15/20251,660,000 shares $472.80 million -2.9%3.8%3.4 $284.82
3/31/20251,710,000 shares $527.14 million -6.6%3.9%3.6 $308.27
3/15/20251,830,000 shares $562.25 million -25.6%4.2%4.1 $307.24
2/28/20252,460,000 shares $787.10 million +18.8%5.6%6.1 $319.96
2/15/20252,070,000 shares $767.10 million +3.0%4.7%5.8 $370.58
1/31/20252,010,000 shares $705.85 million +1.5%4.6%6.3 $351.17
1/15/20251,980,000 shares $716.05 million +3.1%4.5%6.2 $361.64
12/31/20241,920,000 shares $677.45 million -14.3%4.4%6.1 $352.84
12/15/20242,240,000 shares $810.45 million +7.7%5.1%6.8 $361.81
11/30/20242,080,000 shares $770.62 million -5.9%4.8%6.1 $370.49
11/15/20242,210,000 shares $802.78 million -3.9%5.0%6.1 $363.25
10/31/20242,300,000 shares $860.13 million +5.0%5.2%5.8 $373.97
10/15/20242,190,000 shares $787.46 million -2.2%5.0%5.3 $359.57
9/30/20242,240,000 shares $802.70 million -45.1%5.1%5.1 $358.35
9/15/20244,080,000 shares $1.38 billion -0.2%9.3%8.4 $339.12
8/31/20244,090,000 shares $1.49 billion -1.2%9.4%7.8 $363.55
8/15/20244,140,000 shares $1.34 billion +0.5%9.5%7.5 $323.08
7/31/20244,120,000 shares $1.29 billion -1.2%9.4%7.7 $313.29
7/15/20244,170,000 shares $1.36 billion -5.4%9.6%7.4 $327.26
Iran War Shock: What I Was Told In That Private Meeting (Ad)

You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.tc pixel

Because THIS is the real reason.
6/30/20244,410,000 shares $1.40 billion +0.9%10.1%7.8 $318.55
6/15/20244,370,000 shares $1.26 billion +12.3%10.0%7.5 $288.06
5/31/20243,890,000 shares $1.07 billion +3.2%9.4%7.2 $275.13
5/15/20243,770,000 shares $1.03 billion -2.1%9.1%7.2 $272.69
4/30/20243,850,000 shares $902.17 million -10.9%9.4%7.4 $234.33
4/15/20244,320,000 shares $1.02 billion -11.7%10.0%9.4 $235.08
3/31/20244,890,000 shares $1.12 billion +154.7%11.3%11.3 $229.72
3/15/20241,920,000 shares $452.70 million +64.1%4.4%4.7 $235.78
2/29/20241,170,000 shares $264.00 million +0.9%2.7%3 $225.64
2/15/20241,160,000 shares $248.87 million +11.5%2.7%3.3 $214.54
1/31/20241,040,000 shares $223.37 million -11.9%N/A3.3 $214.78
1/15/20241,180,000 shares $258.48 million +7.3%N/A3.6 $219.05
12/31/20231,100,000 shares $241.88 million -15.4%N/A3.5 $219.89
12/15/20231,300,000 shares $320.39 million +14.0%N/A4.2 $246.45
11/30/20231,140,000 shares $273.60 million +0.9%N/A4.2 $240.00
11/15/20231,130,000 shares $259.06 million +4.6%N/A4.4 $229.26
10/31/20231,080,000 shares $240.69 million +4.9%N/A3.6 $222.86
10/15/20231,030,000 shares $240.15 million +7.1%N/A3.4 $233.16
9/30/2023962,200 shares $217.33 million -13.3%N/A3.1 $225.87
9/15/20231,110,000 shares $244.47 million +1.8%N/A3.4 $220.24
8/31/20231,090,000 shares $244.55 million -42.3%N/A3.3 $224.36
8/15/20231,890,000 shares $445.53 million +94.6%N/A5.1 $235.73
7/31/2023971,100 shares $235.71 million -2.2%N/A2.7 $242.72
7/15/2023992,600 shares $230.28 million -8.1%N/A2.6 $232.00
6/30/20231,080,000 shares $238.41 million -5.3%N/A2.8 $220.75
6/15/20231,140,000 shares $261.73 million +9.6%N/A2.7 $229.59
5/31/20231,040,000 shares $218.13 million -22.4%N/A2.2 $209.74
5/15/20231,340,000 shares $287.30 million -8.2%N/A2.4 $214.40
4/30/20231,460,000 shares $335.99 million +6.6%N/A2.5 $230.13
4/15/20231,370,000 shares $313.35 million -3.5%N/A2.5 $228.72
3/31/20231,420,000 shares $318.02 million +6.0%N/A2.6 $223.96
3/15/20231,340,000 shares $291.45 million +0.8%N/A2.6 $217.50
2/28/20231,330,000 shares $327.23 million -5.0%N/A2.8 $246.04
2/15/20231,400,000 shares $354.70 million +11.1%3.1%3.6 $253.36
1/31/20231,260,000 shares $331.59 million -3.8%2.8%3.5 $263.17
1/15/20231,310,000 shares $341.96 million -1.5%2.9%3.4 $261.04
12/30/20221,330,000 shares $369.86 million +20.9%3.0%3.5 $278.09
12/15/20221,100,000 shares $303.44 million -17.9%2.5%3 $275.85
11/30/20221,340,000 shares $375.05 million -5.0%3.0%3.6 $279.89
11/15/20221,410,000 shares $365.36 million +6.8%3.2%3.8 $259.12
10/31/20221,320,000 shares $304.30 million -7.0%3.0%3.5 $230.53
10/15/20221,420,000 shares $307.34 million +6.8%3.2%3.9 $216.44
9/30/20221,330,000 shares $278.48 million +7.3%3.0%3.5 $209.38
9/15/20221,240,000 shares $273.59 million +41.4%2.8%3.1 $220.64
8/31/2022877,000 shares $198.75 million -18.0%2.0%2 $226.62
8/15/20221,070,000 shares $233.65 million +1.9%2.4%2.2 $218.36
7/31/20221,050,000 shares $242.62 million -11.0%2.4%2.1 $231.07
7/15/20221,180,000 shares $283.29 million -3.3%2.7%2.4 $240.08
6/30/20221,220,000 shares $287.48 million -6.9%2.8%2.5 $235.64
6/15/20221,310,000 shares $288.32 million -16.0%3.0%2.6 $220.09
ALT SL: New Patent Reveals Elon Musk’s Next Breakthrough: M.A.G.I. (Ad)

Jeff Brown and Marc Chaikin - two investors who spotted Nvidia a decade ago - are now pointing to Elon Musk's latest AI patent as the catalyst behind their next major call. They say a market pattern with a 100% historical track record is converging with this new breakthrough by end of month. The last time conditions aligned like this, investors had the chance to turn $10,000 into as much as $350,000 in roughly 12 months. Brown and Chaikin have released the full details for investors who want to get ahead of it.tc pixel

See Jeff Brown and Marc Chaikin's full analysis and next steps here
5/31/20221,560,000 shares $359.33 million -12.4%3.5%3.2 $230.34
5/15/20221,780,000 shares $326.52 million +58.9%4.0%3.6 $183.44
4/30/20221,120,000 shares $198.87 million +8.7%2.5%2.5 $177.56
4/15/20221,030,000 shares $197.67 million -38.3%2.3%2.3 $191.91
3/31/20221,670,000 shares $299.61 million +67.0%3.8%3.5 $179.41
3/15/20221,000,000 shares $178.82 million -32.0%2.3%2.3 $178.82
2/28/20221,470,000 shares $244.31 million -8.1%3.3%3.4 $166.20
2/15/20221,600,000 shares $326.86 million -9.6%3.6%3.8 $204.29
1/31/20221,770,000 shares $357.31 million +37.2%4.0%4.5 $201.87
1/15/20221,290,000 shares $276.01 million +19.4%2.9%3.1 $213.96
12/31/20211,080,000 shares $233.37 million -21.7%2.5%2.7 $216.08
12/15/20211,380,000 shares $269.96 million -22.0%3.1%3.4 $195.62
11/30/20211,770,000 shares $335.42 million -5.9%4.0%4.6 $189.50
11/15/20211,880,000 shares $385.46 million -21.3%4.3%5.1 $205.03
10/29/20212,390,000 shares $455.92 million +18.3%5.4%6.5 $190.76
10/15/20212,020,000 shares $377.88 million -14.4%4.5%5.5 $187.07
9/30/20212,360,000 shares $435.61 million -4.5%5.3%7 $184.58
9/15/20212,470,000 shares $504.55 million -23.8%5.6%7.6 $204.27
8/31/20213,240,000 shares $696.21 million +68.8%7.4%9.8 $214.88
8/13/20211,920,000 shares $389.03 million +18.5%4.4%5.4 $202.62
7/30/20211,620,000 shares $294.73 million -3.6%3.7%4.7 $181.93

UTHR Short Interest - Frequently Asked Questions

Short interest is the volume of United Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 2,117,787 shares of UTHR short. 5.46% of United Therapeutics' shares are currently sold short. Learn More on United Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. UTHR shares currently have a short interest ratio of 2.9. Learn More on United Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.46% of United Therapeutics' floating shares are currently sold short.

United Therapeutics saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 2,117,787 shares, an increase of 3.2% from the previous total of 2,052,888 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

5.46% of United Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to United Therapeutics: Regeneron Pharmaceuticals, Inc. (3.55%), Alnylam Pharmaceuticals, Inc. (4.38%), Biogen Inc. (3.89%), Incyte Corporation (6.32%), Neurocrine Biosciences, Inc. (5.77%), Exelixis, Inc. (11.66%), Madrigal Pharmaceuticals, Inc. (18.56%), BioMarin Pharmaceutical Inc. (7.26%), Ionis Pharmaceuticals, Inc. (10.74%), Halozyme Therapeutics, Inc. (11.44%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($82.01 billion), Invesco QQQ ($47.15 billion), iShares Russell 2000 ETF ($24.07 billion), Nebius Group N.V. ($16.85 billion), Western Digital Corporation ($14.29 billion), SPDR S&P Biotech ETF ($11.89 billion), VanEck Semiconductor ETF ($11.29 billion), KLA Corporation ($10.37 billion), iShares 20+ Year Treasury Bond ETF ($8.78 billion), and Lumentum Holdings Inc. ($8.29 billion). View all of the most shorted stocks.

Short selling UTHR is an investing strategy that aims to generate trading profit from United Therapeutics as its price is falling. UTHR shares are trading down $2.74 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for United Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of UTHR, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including UTHR, twice per month. The most recent reporting period available is June, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like UTHR:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:UTHR) was last updated on 7/10/2026 by MarketBeat.com Staff.
From Our Partners
The Lithium Gold Rush Minted A New $1B Unicorn
The Lithium Gold Rush Minted A New $1B Unicorn This lithium producer surpassed a $1B private valuation, joi...
EnergyX | Sponsoredtc pixel
What Saudi Arabia just did to the dollar changes everything
In June 2024, a 50-year arrangement tying Saudi oil to the U.S. dollar quietly expired. Garrett Goggin, CFA, C...
Golden Portfolio | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The only metrics you should watch as a day trader.
Day traders and swing traders don't need the same metrics - and using the wrong ones costs you edge. After 40 ...
The TradingPub | Sponsoredtc pixel
BlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely, LLC | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Trump’s $250 Bill – See Immediately
Former Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...
Stansberry Research | Sponsoredtc pixel
When I found Rolls-Royce under $2, most people thought I was crazy
In 2022, Karim Rahemtulla recommended Rolls-Royce when it traded under $2. The stock climbed more than 1,100% ...
Monument Traders Alliance | Sponsoredtc pixel